NO832734L - Fremgangsmaate for fremstilling av terapeutisk aktive 4,7-alkano-isoindol-derivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 4,7-alkano-isoindol-derivater

Info

Publication number
NO832734L
NO832734L NO832734A NO832734A NO832734L NO 832734 L NO832734 L NO 832734L NO 832734 A NO832734 A NO 832734A NO 832734 A NO832734 A NO 832734A NO 832734 L NO832734 L NO 832734L
Authority
NO
Norway
Prior art keywords
methyl
mixture
hours
solution
isoindole
Prior art date
Application number
NO832734A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Charles Mckanzie
William Joseph Fanshawe
Joseph William Epstein
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO832734L publication Critical patent/NO832734L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/724,7-Endo-alkylene-iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/724,7-Endo-alkylene-iso-indoles
    • C07D209/764,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO832734A 1982-07-28 1983-07-27 Fremgangsmaate for fremstilling av terapeutisk aktive 4,7-alkano-isoindol-derivater NO832734L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40249482A 1982-07-28 1982-07-28

Publications (1)

Publication Number Publication Date
NO832734L true NO832734L (no) 1984-01-30

Family

ID=23592140

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832734A NO832734L (no) 1982-07-28 1983-07-27 Fremgangsmaate for fremstilling av terapeutisk aktive 4,7-alkano-isoindol-derivater

Country Status (14)

Country Link
EP (1) EP0100426A1 (cs)
JP (1) JPS5933261A (cs)
KR (1) KR840005424A (cs)
AU (1) AU1734183A (cs)
DK (1) DK344083A (cs)
ES (1) ES8504125A1 (cs)
FI (1) FI832716L (cs)
GR (1) GR77560B (cs)
IL (1) IL69150A0 (cs)
NO (1) NO832734L (cs)
PH (1) PH18828A (cs)
PL (1) PL243202A1 (cs)
PT (1) PT77114B (cs)
ZA (1) ZA835505B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016155A2 (en) 2005-07-27 2007-02-08 Dov Pharmaceutical, Inc. Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
KR101294014B1 (ko) * 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
JP5749176B2 (ja) * 2008-12-16 2015-07-15 スノビオン プハルマセウトイカルス インコーポレイテッド トリプル再取込み阻害剤及びそれらの使用方法
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
CN112673010B (zh) * 2018-10-17 2023-10-27 国立大学法人大阪大学 化合物及其制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2112548B1 (cs) * 1970-11-09 1976-07-02 Eisai Co Ltd
US3917642A (en) * 1971-11-19 1975-11-04 Cities Service Co Brominated tricyclic imide flame retardants

Also Published As

Publication number Publication date
ES524479A0 (es) 1985-04-01
PT77114B (en) 1986-01-27
FI832716A7 (fi) 1984-01-29
IL69150A0 (en) 1983-11-30
EP0100426A1 (en) 1984-02-15
DK344083A (da) 1984-01-29
PL243202A1 (en) 1985-07-02
KR840005424A (ko) 1984-11-12
GR77560B (cs) 1984-09-24
PH18828A (en) 1985-10-07
DK344083D0 (da) 1983-07-27
AU1734183A (en) 1984-02-02
FI832716L (fi) 1984-01-29
FI832716A0 (fi) 1983-07-27
ZA835505B (en) 1984-04-25
PT77114A (en) 1983-08-01
JPS5933261A (ja) 1984-02-23
ES8504125A1 (es) 1985-04-01

Similar Documents

Publication Publication Date Title
DK174161B1 (da) Anellerede indolderivater, fremgangsmåde til deres fremstilling og fremgangsmåde til fremstilling af farmaceutisk præparat indeholdende dem
US6166040A (en) Indole compounds
EP0655440A2 (de) Indol derivate
EP0636609A1 (fr) Dérivés du 1-benzyl-1,3-dihydro-indol-2-one, leur préparation, les compositions pharmaceutiques en contenant
AU596206B2 (en) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-hydro-5h- 2,3- benzodiazepine acid addition salts thereof and process for preparing same
AU1940900A (en) Functionalized heterocycles as chemokine receptor modulators
JPH0745470B2 (ja) 6−置換−4−ジアルキルアミノテトラヒドロベンズ[c,dインドール類の合成中間体
US4210648A (en) II-Aminoacyl-5,11-dihydro-6H-pyrido(2,3-B) (1,4)benzodiazepin-6-ones and salts thereof
US4853391A (en) Pyrido[1,2-a]indoles and their use as cardiovascular
EP0005365B1 (en) Pyrano and thiopyrano (3,4-b) indole derivatives, processes for their preparation and pharmaceutical compositions containing them
US4604397A (en) Certain benzo-(pyrano and thiopyrano)-pyridines, useful as CNS agents
EP0033767B1 (en) Indolobenzoxazines, processes for preparing and pharmaceutical compositions containing the same
NO160612B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive beta-karbolinderivater.
US4282240A (en) Amino substituted tetrahydrobenzindoles
NO832734L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4,7-alkano-isoindol-derivater
RU2155757C2 (ru) Производные 1-[2-(замещенный винил)]-3,4-дигидро-5h-2,3-бензодиазепина, способ их получения, фармацевтический состав, способ получения фармацевтического состава и способ ингибирования конвульсий.
DE69411143T2 (de) Tryptamin analoge mit 5-ht1d selektivität
US4273773A (en) Antihypertensive tricyclic isoindole derivatives
US4529736A (en) 3a-(Substituted phenyl)-2,3,3a,4,7,7a-hexahydro[or 3a-(substituted-phenyl)octahydro]-4,7-alkano-1H-isoindoles for treating depression in warm-blooded animals
US4309348A (en) Tricyclic indole derivatives
DE69412980T2 (de) Eburnan-Derivate, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
FR2760014A1 (fr) Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK153149B (da) Analogifremgangsmaade til fremstilling af hydroxyaminoeburnanderivater eller farmaceutisk acceptable syreadditionssalte eller optisk aktiv isomerer deraf, samt octahydroindolokinolizin-monoesterderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
DK169581B1 (da) 5,6,7,8-tetrahydro-beta-carbolinderivater og fremgangsmåde til deres fremstilling
EP0017727A1 (de) Polysubstituierte Diazatricyclen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen